Physician profile
Lawrence T Krupa
NPI 1558430512
$324.30
in general payments reported to CMS, 2019-2025
9 companies · $227 in 2025
The $227 reported for 2025 was more than what 76% of Developmental - Behavioral Pediatrics providers received nationally (typical 2025 total: $79.84).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.66 · 2023: $12.99 · 2024: $23.57 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $76.25 | 2025 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $52.73 | 2023-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $43.85 | 2019-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $38.14 | 2019 | |
| Bausch Health US, LLC | $38.05 | 2025 | Aplenzin |
| Alkermes, INC. | $29.97 | 2025 | Lybalvi |
| Supernus Pharmaceuticals, INC. | $17.40 | 2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $16.75 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Krupa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.